A detailed history of Colrain Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Colrain Capital LLC holds 22,750 shares of ABBV stock, worth $4.1 Million. This represents 5.09% of its overall portfolio holdings.

Number of Shares
22,750
Previous 22,750 -0.0%
Holding current value
$4.1 Million
Previous $3.49 Million 12.4%
% of portfolio
5.09%
Previous 5.45%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $385,336 - $489,888
-2,800 Reduced 10.96%
22,750 $3.49 Million
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $107,430 - $135,930
1,000 Added 4.07%
25,550 $3.46 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $319,200 - $362,340
3,000 Added 13.92%
24,550 $2.65 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $315,630 - $351,630
3,000 Added 16.17%
21,550 $2.43 Million
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $1.9 Million - $2.09 Million
18,550 New
18,550 $2.01 Million
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $334,275 - $392,329
-3,891 Reduced 14.63%
22,712 $1.99 Million
Q2 2020

Aug 10, 2020

SELL
$73.37 - $98.18 $207,783 - $278,045
-2,832 Reduced 9.62%
26,603 $2.61 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $2.24 Million - $3.4 Million
-34,735 Closed
0 $0
Q4 2019

Jan 30, 2020

SELL
$72.13 - $90.25 $162,292 - $203,062
-2,250 Reduced 6.08%
34,735 $3.08 Million
Q3 2019

Oct 23, 2019

BUY
$62.98 - $75.72 $990,360 - $1.19 Million
15,725 Added 73.97%
36,985 $2.8 Million
Q2 2019

Aug 06, 2019

BUY
$65.7 - $83.98 $1.08 Million - $1.39 Million
16,510 Added 347.58%
21,260 $1.55 Million
Q1 2019

May 02, 2019

SELL
$77.14 - $90.79 $192,850 - $226,975
-2,500 Reduced 34.48%
4,750 $383,000
Q4 2017

Feb 07, 2018

SELL
$89.56 - $98.21 $23,106 - $25,338
-258 Reduced 3.44%
7,250 $701,000
Q3 2017

Nov 02, 2017

BUY
$69.85 - $89.22 $524,433 - $669,863
7,508
7,508 $667,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Colrain Capital LLC Portfolio

Follow Colrain Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colrain Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colrain Capital LLC with notifications on news.